[HTML] sciencedirect.com

[HTML][HTML] NIR-responsive molybdenum (Mo)-based nanoclusters enhance ROS scavenging for osteoarthritis therapy

G Shi, H Jiang, F Yang, Z Lin, M Li, J Guo, X Liao… - Pharmacological …, 2023 - Elsevier
Osteoarthritis (OA) is one of the most prevalent musculoskeletal disorders globally, and
treating OA remains a significant challenge. Currently, pharmacological treatments primarily …
被引用次数：9 相关文章

NIR-responsive molybdenum (Mo)-based nanoclusters enhance ROS scavenging for osteoarthritis therapy.

G Shi, H Jiang, F Yang, Z Lin, M Li, J Guo… - Pharmacological …, 2023 - europepmc.org
Osteoarthritis (OA) is one of the most prevalent musculoskeletal disorders globally, and
treating OA remains a significant challenge. Currently, pharmacological treatments primarily …

NIR-responsive molybdenum (Mo)-based nanoclusters enhance ROS scavenging for osteoarthritis therapy

G Shi, H Jiang, F Yang, Z Lin, M Li, J Guo… - Pharmacological … - pubmed.ncbi.nlm.nih.gov
Osteoarthritis (OA) is one of the most prevalent musculoskeletal disorders globally, and
treating OA remains a significant challenge. Currently, pharmacological treatments primarily …